Zhan P - Search Results

1

XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis.

Qiu LX, Mao C, Yao L, Yu KD, Zhan P, Chen B, Liu HG, Yuan H, Zhang J, Xue K, Hu XC. Qiu LX, et al. Among authors: zhan p. Breast Cancer Res Treat. 2010 Jul;122(2):489-93. doi: 10.1007/s10549-009-0726-1. Epub 2010 Jan 5. Breast Cancer Res Treat. 2010. PMID: 20049524 Review.

2

Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis.

Zhan P, Wang J, Lv XJ, Wang Q, Qiu LX, Lin XQ, Yu LK, Song Y. Zhan P, et al. J Thorac Oncol. 2009 Sep;4(9):1094-103. doi: 10.1097/JTO.0b013e3181a97e31. J Thorac Oncol. 2009. PMID: 19687765 Free article. Review.

3

CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians.

Zhan P, Wang J, Zhang Y, Qiu LX, Zhao SF, Qian Q, Wei SZ, Yu LK, Song Y. Zhan P, et al. Lung Cancer. 2010 Jul;69(1):19-25. doi: 10.1016/j.lungcan.2009.09.001. Epub 2009 Sep 30. Lung Cancer. 2010. PMID: 19796841

4

Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects.

Qiu LX, Yuan H, Yu KD, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC. Qiu LX, et al. Among authors: zhan p. Breast Cancer Res Treat. 2010 Jun;121(3):703-8. doi: 10.1007/s10549-009-0636-2. Epub 2009 Nov 21. Breast Cancer Res Treat. 2010. PMID: 19936916

5

MnSOD Val16Ala polymorphism and prostate cancer susceptibility: a meta-analysis involving 8,962 subjects.

Mao C, Qiu LX, Zhan P, Xue K, Ding H, Du FB, Li J, Chen Q. Mao C, et al. Among authors: zhan p. J Cancer Res Clin Oncol. 2010 Jul;136(7):975-9. doi: 10.1007/s00432-009-0742-x. Epub 2009 Dec 10. J Cancer Res Clin Oncol. 2010. PMID: 20012093

6

Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.

Qiu LX, Yao L, Mao C, Yu KD, Zhan P, Chen B, Yuan H, Zhang J, Xue K, Hu XC. Qiu LX, et al. Among authors: zhan p. Breast Cancer Res Treat. 2010 Jul;122(2):521-5. doi: 10.1007/s10549-009-0731-4. Epub 2010 Jan 7. Breast Cancer Res Treat. 2010. PMID: 20054636 Review.

7

IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls.

Qiu LX, Yao L, Yuan H, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC. Qiu LX, et al. Among authors: zhan p. Breast Cancer Res Treat. 2010 Aug;122(3):867-71. doi: 10.1007/s10549-010-0739-9. Epub 2010 Jan 19. Breast Cancer Res Treat. 2010. PMID: 20084546

8

BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects.

Qiu LX, Yao L, Xue K, Zhang J, Mao C, Chen B, Zhan P, Yuan H, Hu XC. Qiu LX, et al. Among authors: zhan p. Breast Cancer Res Treat. 2010 Sep;123(2):487-90. doi: 10.1007/s10549-010-0767-5. Epub 2010 Feb 5. Breast Cancer Res Treat. 2010. PMID: 20135345

9

TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47,817 subjects.

Qiu LX, Yao L, Mao C, Chen B, Zhan P, Xue K, Zhang J, Yuan H, Hu XC. Qiu LX, et al. Among authors: zhan p. Breast Cancer Res Treat. 2010 Sep;123(2):563-7. doi: 10.1007/s10549-010-0781-7. Epub 2010 Feb 9. Breast Cancer Res Treat. 2010. PMID: 20143152

10

Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects.

Qiu LX, Yao L, Mao C, Chen B, Zhan P, Yuan H, Xue K, Zhang J, Hu XC. Qiu LX, et al. Among authors: zhan p. Breast Cancer Res Treat. 2010 Sep;123(2):543-7. doi: 10.1007/s10549-010-0777-3. Epub 2010 Feb 9. Breast Cancer Res Treat. 2010. PMID: 20143154

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

971 results

Search Page

Filters